Stay updated on Selinexor Combo for High-Risk Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.

Latest updates to the Selinexor Combo for High-Risk Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe latest version adds Results Posted, Adverse Events, and Outcome Measures (Results) along with an updated Study Status and revision v3.7.0. Previously listed items like Results Submitted and Revision: v3.6.6 have been removed, indicating a transition from submission to public posting of trial results.SummaryDifference0.7%

- Check36 days agoChange DetectedThe revision history now shows a new entry for v3.6.6 and removes the previous v3.6.5 entry, updating the page's revision log to reflect the latest version.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record history now shows a new revision (v3.6.5) returned on 2026-07-31, bringing in newly surfaced sections such as Adverse Events, Baseline Characteristics, Participant Flow, Outcome Measures (Results), Study Design, and Study Status to the study record. This update broadens the displayed data and status details for the trial.SummaryDifference1%

- Check72 days agoChange DetectedA new revision entry, v3.6.4, has been added to the record history. This update replaces the previous revision, v3.6.3, signaling an update to the historical record.SummaryDifference0.1%

- Check86 days agoChange DetectedThe history now shows 'Results Submitted' replacing 'No Results Posted'. This indicates that the trial results have been submitted and will appear in the record for review by researchers and participants.SummaryDifference0.1%

- Check93 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, and the previous v3.6.2 entry was removed, indicating the latest version of the record history is now reflected.SummaryDifference0.1%

Stay in the know with updates to Selinexor Combo for High-Risk Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.